• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Pediatric Transplantation

    Pediatric Transplantation

    JournalISSN 1397-3142eISSN 1399-3046中科院 医学 4区

    年发文量

    研究主题

    论文(8326)

    排序
    1Reply to UNEARTH Methods Letter to the Editor by Imamura
    Vikas R. Dharnidharka
    2026
    引用
    AI阅读
    加入学术空间
    2Understanding the Immune Response Changes to Clinical Interventions for Epstein-Barr Virus Infection Prior to Lymphoma Development in Children after Organ Transplants (UNEARTH)
    Vikas R. Dharnidharka,Claire Bocchini,Swati Choudhry,Elizabeth Moulton,Lujain Jaza, Joseph Dumayas,Camila Macedo, Elizabeth Zaragoza,Maryam Mysorewala,Michelle Becker-Hapak,Mark Foster,Mansi Agarwal,

    Background Post-transplant lymphoproliferative disorders (PTLD) remain a major complication of solid organ transplants (SOT), occurring in 1%-10% of patients, but in greater proportions in children. About 50%-80% of cases are Epstein-Barr Virus (EBV) associated, through partially known and still unknown mechanisms. Even in EBV seronaive SOT recipients, transplant of an SOT from an EBV seropositive donor does not always lead to peripheral blood EBV replication. Longitudinal peripheral blood EBV DNA nucleic acid testing (NAT) after SOT has not improved the individual prediction of PTLD occurrence, likely due to variable SOT recipient immune responses.Methods This prospective study is designed to assess longitudinal and comprehensive T and NK cell phenotyping and responses to peripheral blood EBV replication via multispectral flow cytometry and other assays. We will also compare local to central EBV NAT values and test whether torquetenovirus NAT can act as a simpler assay to predict EBV clearance. We will collect 1390 blood samples across 5 time points in the first year after 347 enrolled (278 completed) SOTs (kidney, liver, heart, lung or intestine) from three major pediatric SOT centers in the U.S.A.Results As of June 30, 2025, our study has enrolled 133 participants, of whom 110 have received an organ transplant (27% Hispanic ethnicity, 16% black race, median age 8 years, across all 4 major SOT types).Conclusions By study end, we will know the global immune responses to EBV replication across a spectrum of clinical pediatric SOT situations. We expect to find key immune mechanisms that will predict poor or delayed EBV clearance despite clinical interventions. These findings may lead to new translational immunotherapy approaches to treat EBV DNaemia or prevent PTLD. We expect that our findings will also inform EBV oncogenesis in other immunocompromised or immunocompetent populations.

    2026
    引用
    AI阅读
    加入学术空间
    3Posttransplant Anemia in Pediatric Kidney Transplant Recipients: from Prevalence to Longitudinal Phenotyping
    Teruhiko Imamura
    2026
    引用
    AI阅读
    加入学术空间
    4Transplant Care and Immunosuppression Practices at Pediatric Kidney Transplant Centers and Their Association with Re‐transplantation after Graft Failure
    Erica Winnicki, Charles E. McCulloch,Isabelle Lopez, Reese Guitche, Feng Lin,Elaine Ku

    ABSTRACT Background There is a paucity of data on how to manage children with failed kidney transplants in order to optimize their access to future transplants. Our objective was to understand how system‐level differences in transplant care and immunosuppression management after graft failure are associated with access to a second kidney transplant in children. Methods To achieve our objective, we surveyed US pediatric kidney transplant centers about their practices. We then examined the relation between each center's approach in delivering follow‐up care, transitioning care, and immunosuppression management after graft failure with access of children to re‐transplantation between 2005 and 2019 according to the US Renal Data System using Fine‐Gray models. Results 43/84 surveyed programs who served 1388 pediatric patients with graft failure responded. Although programs had variable practices in terms of frequency of follow‐up visits and age of transition from pediatric to adult care, these practices were not associated with access to re‐transplantation. Regarding immunosuppression management, pediatric kidney transplant recipients at centers whose respondents did not oversee the weaning of immunosuppression after graft failure had a 37% reduced likelihood of re‐transplantation (95% CI: 17%–53%). Centers that continued immunosuppression in children receiving dialysis after graft failure until there was no residual graft function had a 39% reduced likelihood of re‐transplantation (95% CI: 17%–55%) compared to centers that withdrew immunosuppression after a pre‐defined period. Conclusions Management of pediatric transplant recipients with graft failure is variable at US pediatric kidney transplant centers, and variability in immunosuppression management practices was associated with the likelihood of re‐transplantation.

    2026
    引用
    AI阅读
    加入学术空间
    5Ethical Considerations in Pediatric Deceased Solid Organ Donation
    Kelsey Van Noy,Mithya Lewis‐Newby, Douglas Diekema,Emily Berkman, Daniel H. Kim,Robert Ohman,Jonna Clark

    ABSTRACT Pediatric deceased organ donation raises distinct ethical challenges involving death determination, parental authority, and emerging organ recovery and preservation technologies. Although many of these controversies extend beyond pediatrics, they are shaped by a context in which authorization rests with parents, donation is rare and technically complex, and families are navigating the loss of their child. This review synthesizes established and emerging controversies in deceased organ donation through a pediatric lens, examining definitions and determinations of death, conflicts between end‐of‐life care and organ preservation, societal and individual trust, the distinction between authorization and informed consent, normothermic regional perfusion, and the dead donor rule as the foundation of deceased donation. The controversies reflect a central tension: the desire to save lives through organ transplantation and the obligation to protect the dying child from harm. As transplantation medicine evolves, the ethical frameworks guiding donation must continue to adapt to protect donors, support families, and maintain public trust.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 8326 篇论文

    高被引作者

    作者引用发文
    Bernardo Nadal-Ginard80251
    Baosheng Li80251
    Ronald Mckay80251
    Annarosa Leri80251
    Piero Anversa80251
    J Kajstura80251
    James Pickel80251
    I. Jakoniuk80251
    Stefano Chimenti80251
    Donald Orlic80251

    高产作者

    作者引用发文
    Anne I. Dipchand1896115
    Mehmet Haberal591113
    Mureo Kasahara1447110
    George Mazariegos1405109
    Stephen Marks501108
    Tom D. Blydt-Hansen78998
    Seisuke Sakamoto116397
    Piotr Kaliciński45484
    Guido Filler104080
    Akinari Fukuda75676

    相关期刊

    Clinical Transplantation
    Transplantation Reviews
    Transplantation Proceedings
    Annals of transplantation
    World journal of transplantation
    Current Treatment Options in Pediatrics
    Transplantation direct
    Pediatric Nephrology
    Pediatrics International
    Experimental and Clinical Transplantation